FUNDAMENTALS · Fundamentals · ID Healthcare

PT Mark Dynamics Indonesia (MARK) Fundamentals 2026 — P/E 12.5x, Revenue Analysis | SniperIQ

PT Mark Dynamics Indonesia (MARK) is a ID-listed Healthcare company in Medical - Instruments & Supplies with a market capitalization of Rp3.71T, trading at Rp975.00 on the JKT. This SniperIQ fundamentals page covers PT Mark Dynamics Indonesia's valuation (P/E 12.5x, P/B 0.0x), profitability (net margin 33.6%), revenue (Rp837.3B in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.

Market CapRp3.71T
P/E (TTM)12.5x
Net Margin33.6%
Revenue (FY25)Rp837.3B

Full research coverage

  • 8-Quarter Revenue & Margin Trend
  • Debt Maturity & Coverage
  • Peer Valuation Comparison
  • Free Cash Flow & Owner Earnings
  • AI Signal + Institutional Flow
  • DCF Valuation Model

Frequently Asked Questions

What is PT Mark Dynamics Indonesia's market cap?

PT Mark Dynamics Indonesia (MARK) has a market capitalization of approximately Rp3.71T, trading at Rp975.00 on the JKT. Market cap moves with the live share price.

What is PT Mark Dynamics Indonesia's P/E ratio?

PT Mark Dynamics Indonesia's trailing twelve-month P/E ratio is 12.5x, with a price-to-book (P/B) of 0.0x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.

How profitable is PT Mark Dynamics Indonesia?

PT Mark Dynamics Indonesia runs a net profit margin of 33.6%, a gross margin of 48.5%, and an operating margin of 41.5%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.

How much revenue does PT Mark Dynamics Indonesia generate?

PT Mark Dynamics Indonesia reported revenue of Rp837.3B for fiscal year 2025, with net income of Rp283.9B and earnings per share (EPS) of 74.71. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.

Does PT Mark Dynamics Indonesia pay a dividend?

PT Mark Dynamics Indonesia offers a trailing dividend yield of about 9.2%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.

Is PT Mark Dynamics Indonesia financially healthy?

PT Mark Dynamics Indonesia carries a debt-to-equity ratio of 0.01x and a current ratio of 6.73x, with a market beta of 0.26. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.

Is PT Mark Dynamics Indonesia a good stock to buy in 2026?

SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For PT Mark Dynamics Indonesia (MARK) the key facts are: market cap Rp3.71T, P/E 12.5x, revenue Rp837.3B, 52-week range 585-1140. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.

Track PT Mark Dynamics Indonesia's full fundamentals live

Get PT Mark Dynamics Indonesia's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.

Related: HLB (028300) fundamentals · Sam Chun Dang Pharm (000250) fundamentals · ABL Bio (298380) fundamentals · LigaChem Biosciences (141080) fundamentals · All stock fundamentals · AI signal library
Research Hubs: Fundamentals library · Screeners · Institutional positioning · Super investors · Daily signals · Platform comparisons